<ARTICLE> 5 <LEGEND> This schedule contains summary information extracted from the Statements of Operations and Balance Sheets of InVitro International and is qualified in its entirety by reference to such financial statements. </LEGEND> <CIK> 0000872610 <NAME> INVITRO INTERNATIONAL <MULTIPLIER> 1000 <FISCAL-YEAR-END> Sep-30-1996 <PERIOD-START> Oct-01-1995 <PERIOD-END> Jun-30-1996 <PERIOD-TYPE> 9-MOS <CASH> 1,719 <SECURITIES> 0 <RECEIVABLES> 222 <ALLOWANCES> 15 <INVENTORY> 331 <CURRENT-ASSETS> 2,306 <PP&E> 1,038 <DEPRECIATION> 793 <TOTAL-ASSETS> 2,741 <CURRENT-LIABILITIES> 362 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 24,782 <OTHER-SE> (22,403) <TOTAL-LIABILITY-AND-EQUITY> 2,741 <SALES> 812 <TOTAL-REVENUES> 812 <CGS> 511 <TOTAL-COSTS> 2,197 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> (55) <INCOME-PRETAX> (1,330) <INCOME-TAX> 0 <INCOME-CONTINUING> (1,330) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (1,330) <EPS-PRIMARY> (0.11) <EPS-DILUTED> (0.11)